GloPID-R is the only alliance of its kind to bring together research funding organizations on a global scale to facilitate an effective research response within 48 hours of a significant outbreak of a new or re-emerging infectious disease with pandemic potential.
The Ebola outbreak has shown the importance of research and innovation at the outset of an epidemic to develop essential diagnostics, vaccines and therapeutics. It is important to think, plan and invest in research and innovation before a health crisis occurs.
GloPID-R does not fund projects directly but rather coordinates and shares information among the funding organizations. That way, research funders can jointly or separately target funds to specific infectious disease research programs. They also stay updated on each other’s research results and keep alert to emerging epidemics. This information cross-sharing allows research funders to be primed and ready to respond when the next Ebola-like epidemic strikes.
Specific objectives of GloPID-R:
- facilitate the exchange of information
- address scientific, legal, ethical and financial challenges,
- implement a ‘One Health’ approach with close cooperation between human and animal health researchers,
- establish a strategic agenda for research response,
- connect infectious disease research networks, and
- actively involve developing countries.
The importance of the GloPID-R alliance was highlighted by G7 leaders in their “Vision for Global Health” published in May 2016
The G7 leaders “acknowledge the importance of ensuring mechanisms to accelerate R&D in public health emergencies, and welcome the action to prevent epidemics such as WHO Blueprint, discussions at Global Health Security Initiative and Global Research Collaboration for Infectious Disease Preparedness (GloPID-R)”
Until now there has been no platform for scientists and research funders to identify the best research solutions and channel the necessary funds rapidly. GloPID-R is designed to save valuable resources, avoiding duplication of efforts and lost time.
26 of the world’s major research funders are represented in GloPID-R today.
- March: Fifth GloPID-R meeting in Seoul
- December: SAB Meeting in Paris
- November: GloPID-R Zika Virus Research Workshop in Sao Paulo, Brazil
- March: Fourth GloPID-R meeting in Washington
- February: New members from India, Canada and Norway join
- January: New members from the US and Italy join
- December: Members conference on Zika virus – New members from Africa and UK join
- September: GloPID-R meeting – New members from Thailand and Brazil join
- May 4-5: Third GloPID-R meeting in Cape Town – New members from Argentina, Germany, Mexico and Japan join
- January: a Secretariat is established to support GloPID-R members and goals
- October: Second GloPID-R meeting in Montreal – 10 founding members agree on a charter outlining GloPID-R’s goals and governance
- The Heads of International (biomedical) Research Funding Organisations (HIRO) agree to create an initiative to facilitate international collaboration between funders in the field of new and re-emerging epidemics
- The European Commission and international funders launch the ‘Global Research Collaboration for Infectious Disease Preparedness’ (GloPID-R)
- October: First GloPID-R meeting in Annecy